A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants
NCT05567510 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2023-02-17
Summary
The purpose of the study is to assess mass balance, biotransformation, and excretion of BMS-986369 following study drug administration.
Conditions
- Healthy Participants
Interventions
- DRUG
-
BMS-986369
Specified dose on specified days
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-20
- Primary Completion
- 2022-12-27
- Completion
- 2022-12-27
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants
NCT05284890 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment
NCT04634149 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB086550
NCT05101369 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
NCT06309394 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.
NCT04086719 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants
NCT04055506 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020
NCT02068053 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects
NCT05868967 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.
NCT06258746 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
NCT03210909 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)
NCT06626464 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04249284 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male Participants
NCT01949610 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356
NCT04147910 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Absorption, Metabolism, and Excretion of [14C]-SKI-O-703 Following a Single Oral Dose in Healthy Male Subjects
NCT05042986 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects
NCT01487239 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects
NCT02880670 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants
NCT03939702 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects
NCT01503866 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment
NCT04225936 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers
NCT04616742 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04536961 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment
NCT07248839 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
NCT02985632 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930
NCT03034486 ·Status: COMPLETED ·Phase: PHASE1